At December 31, 2017, the Company had $260 million of outstanding borrowings under the Credit Facility in addition to outstanding letters of credit of $9.0 million.
During the first quarter of 2018, the Company entered into three interest rate swaps with a notional amount of $150 million to hedge some of its exposure to variability in future LIBOR-based interest payments on variable rate debt.
At December 31, 2017, the Company had $260 million of outstanding borrowings under the Credit Facility in addition to outstanding letters of credit of $9.0 million.
The Company is currently in the process of evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures.
The Company is evaluating these considerations to determine the amount of its foreign subsidiaries’ cumulative earnings it intends to indefinitely reinvest.
There were 337,325 non-vested shares outstanding as of December 31, 2017.
The carrying amounts of cash and cash equivalents, receivables, inventories, payables, debt and other current assets and liabilities approximate fair value because of the short maturity of those instruments.
At December 31, 2017, the Company had approximately $181 million available to borrow under the Credit Facility, and a $250 million increase option, in addition to $41.6 million cash on hand.The increase in amortization expense in the first quarter of 2018 compared to the first quarter of 2017 was mainly due to an increase in amortization of intangibles related to the Morgan Schaffer, NRG, and Mayday acquisitions.
The increase in the first quarter of 2018 compared to the first quarter of 2017 was mainly due to a $1.1 million increase in net sales at TEQ due to higher shipments to medical customers and a $0.9 million increase in net sales at Plastique.
The Company received new orders totaling $200.5 million in the first quarter of 2018 compared to $182.9 million in the first quarter of 2017.
Backlog was $404.1 million at December 31, 2017 compared with $377.1 million at September 30, 2017.
The increase in net sales in the first quarter of 2018 as compared to the first quarter of 2017 was due to a $20.2 million increase in the USG segment, a $3.7 million increase in the Test segment, a $2.0 million increase in the Technical Packaging segment and a $1.2 million increase in the Filtration segment.
The Company evaluates the performance of its operating segments based on EBIT, and provides EBIT on a consolidated basis, which is a non-GAAP financial measure.
The decrease in EBIT as a percent of net sales in the first quarter of 2018 compared to the first quarter of 2017 was mainly due to product mix at Plastique.
The Company does not anticipate a material change in the amount of unrecognized tax benefits in the next twelve months.
The increase in net earnings and diluted earnings per share in the first quarter of 2018 as compared to the first quarter of 2017 was mainly due to the $25.1 million net tax benefit the Company recorded as a result of the Tax Cuts and Jobs Act that was signed into law on December 22, 2017.There has been no material change to the Company’s market risks since September 30, 2017.